Rana Shiv Ps, Ahmed Arif, Kumar Vindo, Chaudhary Prakash K, Khurana Deepa, Mishra Seema
Unit of Anaesthesiology (IRCH), Dr. BRA Institute Rotary Cancer Hospital, AIIMS, New Delhi, India.
Indian J Palliat Care. 2011 May;17(2):162-5. doi: 10.4103/0973-1075.84541.
Morphine has been used for many years to relieve cancer pain. Oral morphine (in either immediate release or modified release form) remains the analgesic of choice for moderate or severe cancer pain. The dose of oral morphine is titrated up to achieve adequate relief from pain with minimal side effects. Antidepressant and anticonvulsant drugs, when used in addition to conventional analgesics, give excellent relief from cancer pain. Most cancer pain responds to pharmacological measures with oral morphine but some pain like neuropathic and bony pain, pain in children and elderly age group, and advanced malignancy pain are very difficult to treat. Here, we report the management of a similar patient of severe cancer pain and the difficulty that we came across during dose titration of oral morphine and adjuvant analgesic.
吗啡已被用于缓解癌症疼痛多年。口服吗啡(即速释或缓释剂型)仍然是中度或重度癌症疼痛的首选镇痛药。口服吗啡的剂量需逐步增加,以在副作用最小的情况下实现充分的疼痛缓解。抗抑郁药和抗惊厥药与传统镇痛药联合使用时,能有效缓解癌症疼痛。大多数癌症疼痛对口服吗啡的药物治疗有反应,但有些疼痛,如神经性和骨痛、儿童和老年患者的疼痛以及晚期恶性肿瘤疼痛,很难治疗。在此,我们报告一例类似的严重癌症疼痛患者的治疗情况,以及在口服吗啡和辅助镇痛药剂量滴定过程中遇到的困难。